WD 40 WDFC
- Market cap
- $3.1B
- PE
- 37.5×
- 10y median 39.2×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 4.4×
- EV/EBIT
- 26.2×
- Revenue, 12 months
- $688M
- +11% on a year ago
- Net margin
- 12.0%
- Free cash flow yield
- 3.2%
WD 40 trades at 37.5× trailing earnings, near its ten-year median. Revenue was $688M over the last twelve months, up 11% on a year earlier with a 12% net margin.
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $140.4M+12% | $139.1M+7% | $155M+9% | $156M+11% | $153.5M+9% | $146.1M+5% | $156.9M+1% | $163.5M+5% | $154.4M+1% | $161.7M+11% | $195.1M+24% | $176.8M+8% | |
| Cost of revenue | $64.9M+7% | $66.2M+3% | $72.7M+4% | $71.6M+5% | $69.4M+7% | $66.4M+0% | $68.8M−5% | $74M+3% | $67.6M−3% | $71.7M+8% | $84.7M+23% | $83.5M+13% |
| Gross profit | $75.6M+18% | $72.9M+10% | $82.4M+15% | $84.3M+17% | $84.1M+11% | $79.7M+9% | $88.1M+7% | $89.4M+6% | $86.8M+3% | $89.9M+13% | $110.4M+25% | $93.3M+4% |
| SG&A | $44.1M+10% | $45M+20% | $45.6M+19% | $49.1M+27% | $50.5M+15% | $49M+9% | $51.5M+13% | $48.9M−1% | $55.3M+10% | $54.8M+12% | $56.7M+10% | $58.2M+19% |
| $24.2M+30% | $20.9M−6% | $27.2M+6% | $24.1M+4% | $25.1M+4% | $23.3M+11% | $27.4M+1% | $28M+17% | $23.3M−7% | $26.3M+13% | $40.3M+47% | $19.1M−32% | |
| Interest expense | $1.1M−2% | $1M−33% | $1.2M−26% | $951K−29% | $873K−24% | $1M+1% | $887K−25% | $660K−31% | $648K−26% | $666K−35% | $794K−11% | $666K+1% |
| Pre-tax income | $23.1M+30% | $19.8M−5% | $25.8M+6% | $22.8M+3% | $24.3M+5% | $22.4M+13% | $27.5M+6% | $27.5M+21% | $22.6M−7% | $25.9M+15% | $39.6M+44% | $18.5M−33% |
| $5.6M+51% | $4.3M−2% | $6M+10% | $6M+6% | $5.3M−5% | −$7.4M | $6.5M+8% | $6.2M+4% | $5.1M−4% | $5.5M | $9.4M+44% | $4.1M−34% | |
| Net income | $17.5M+25% | $15.5M−6% | $19.8M+5% | $16.8M+1% | $18.9M+8% | $29.9M+92% | $21M+6% | $21.2M+27% | $17.5M−8% | $20.3M−32% | $30.2M+44% | $14.4M−32% |
| $1.28+26% | $1.14−6% | $1.46+6% | $1.23+2% | $1.39+9% | $2.19+92% | $1.54+6% | $1.56+27% | $1.28−8% | $1.50−32% | $2.24+46% | $1.06−32% | |
| 13.6M−0% | 13.6M−0% | 13.6M−0% | 13.6M−0% | 13.6M−0% | 13.6M−0% | 13.6M−0% | 13.6M−0% | 13.5M−0% | 13.5M−1% | 13.5M−1% | 13.5M−1% |
EPS, diluted: 16 periods, Q4 FY11 to Q4 FY26: quarter's net income to common over its shares, to the cent.
Diluted shares: 16 periods, Q4 FY11 to Q4 FY26: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Chemicals nearest WD 40's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| WDFCWD 40 | $3.1B | 37.5× | 39.2× | 4.4× | +11% | 12.0% | |
| FULFuller H B | $2.8B | 14.4× | 22.8× | 0.8× | +1% | 5.6% | |
| NGVTIngevity | $2.5B | 50.1× | 20.1× | 2.2× | −4% | 4.7% | |
| IOSPInnospec | $2.5B | 20.3× | 22.3× | 1.3× | +3% | 6.6% | |
| CBTCabot | $3.9B | 21.4× | 14.4× | 1.1× | −5% | 5.2% | |
| AVNTAvient | $4B | 23.5× | 20.3× | 1.2× | +2% | 5.1% | |
| ROGRogers | $2.3B | 50.7× | 34.4× | 2.7× | +7% | 5.3% | |
| CSWCSW Industrials | $4.7B | 36.9× | 34.8× | 3.7× | +30% | 10.2% | |
| BCPCBalchem | $5.5B | 32.9× | 40.9× | 5.0× | +9% | 15.4% | |
| HXLHexcel | $6.1B | 40.8× | 36.2× | 3.1× | +5% | 7.8% | |
| CRONCronos | $1.2B | 16.6× | 24.9× | 6.9× | +37% | 39.1% | |
| Peer median | $3.3B | 28.2× | 23.8× | 2.4× | +4% | 6.1% |
More on WD 40
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #5of 36Chemicals stocks with the highest profit margins
- #4of 13Chemicals stocks cheapest against their own PE history
- #8of 14Chemicals stocks with the fastest earnings growth
Its groups
About
- Industry
- Chemicals
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .